Table of Contents
Print

Are There Anatomical Changes in Dopamine/Norepinephrine Networks in ADHD? 

Yes, numerous studies have identified anatomical changes in the dopamine and norepinephrine networks of individuals with ADHD. These structural differences help explain many of the cognitive and behavioural symptoms associated with the condition, particularly inattention, impulsivity, and emotional dysregulation. 

Brain Structure Differences in Dopamine Pathways 

The dopaminergic system is primarily associated with motivation, reward processing, and executive function. In ADHD, neuroimaging studies have shown reduced volume in subcortical regions such as the striatum and basal ganglia, which are rich in dopamine receptors. These areas are essential for regulating behaviour, filtering distractions, and managing responses to stimuli. Reduced size or delayed maturation in these regions is often linked to the severity of ADHD symptoms. 

Cortical Networks and Norepinephrine 

The norepinephrine system plays a critical role in attention regulation and mental alertness. Anatomical differences have been observed in cortical networks, particularly within the prefrontal cortex, which is densely innervated by norepinephrine neurons originating from the locus coeruleus. In individuals with ADHD, this region often shows thinner cortical thickness or slower development, which correlates with difficulties in attention control and task engagement. 

Interconnected Network Disruptions 

Together, structural changes in these dopamine and norepinephrine networks affect communication between cortical and subcortical brain regions, disrupting the circuits responsible for planning, focus, and emotional regulation. These anatomical changes help confirm that ADHD is not merely behavioural; it is deeply rooted in measurable brain structure differences. 

Visit providers like ADHD Certify for personal consultations to explore how anatomical changes in dopamine/norepinephrine networks contribute to ADHD.

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Dopamine and norepinephrine systems.

Victoria Rowe, MSc, author for my patient advice - mypatientadvice.co.uk

Victoria Rowe, MSc

Author

Victoria Rowe is a health psychologist with a Master’s in Health Psychology and a BS in Applied Psychology. She has experience as a school psychologist, conducting behavioural assessments, developing individualized education plans (IEPs), and supporting children’s mental health. Dr. Rowe has contributed to peer-reviewed research on mental health, including studies on anxiety disorders and the impact of COVID-19 on healthcare systems. Skilled in SPSS, Minitab, and academic writing, she is committed to advancing psychological knowledge and promoting well-being through evidence-based practice.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Rebecca Fernandez, MBBS, author and a reviewer for my patient advice - mypatientadvice.co.uk

Dr. Rebecca Fernandez, MBBS

Reviewer

Dr. Rebecca Fernandez is a UK-trained physician with an MBBS and experience in general surgery, cardiology, internal medicine, gynecology, intensive care, and emergency medicine. She has managed critically ill patients, stabilised acute trauma cases, and provided comprehensive inpatient and outpatient care. In psychiatry, Dr. Fernandez has worked with psychotic, mood, anxiety, and substance use disorders, applying evidence-based approaches such as CBT, ACT, and mindfulness-based therapies. Her skills span patient assessment, treatment planning, and the integration of digital health solutions to support mental well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewer's privacy.